Related Experiment Video
Updated: Feb 21, 2026
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Oncogenic LPCAT1 Accelerates Intrahepatic Cholangiocarcinoma Development Through PI3K/Akt Signaling-Dependent Cell
Enlai Jiang1, Yuwei Chen2, Menglin Chen2
1Department of General Surgery, Xinqiao Hospital, Army Medical University, Chongqing, China.
Background:
Intrahepatic cholangiocarcinoma (ICC), a primary liver malignancy arising from the intrahepatic bile ducts, represents one of the most aggressive tumors with a dismal prognosis and ranks second only to hepatocellular carcinoma (HCC) in prevalence. Dysregulation of phospholipid metabolism is increasingly being implicated in tumorigenesis, and lysophosphatidylcholine acyltransferase (LPCAT) family members-key regulatory enzymes-play critical roles in various cancers, including HCC. However, their expression profiles and biological functions in ICC remain undefined.
Methods:
Immunochemistry experiments were used to examine the expression of LPCAT1 in ICC tissues. Both in vitro and in vivo functional assays were performed to investigate the functional role of LPCAT1 in regulating cell proliferation, apoptosis, and tumor growth. RNA sequencing and multiplex immunohistochemistry were used to explore the signaling pathways regulated by LPCAT1.
Results:
We identified LPCAT1 as the most significantly upregulated LPCAT in both human and murine ICC tissues. Elevated LPCAT1 expression correlated with poor prognosis in ICC patients. Genetic silencing or overexpression of LPCAT1 dramatically altered the proliferation capacity of ICC cells both in vitro and in vivo. Furthermore, liver-specific LPCAT1 knockout mice (LPCAT1LCKO) exhibited significantly attenuated liver tumor burden in a chemically induced model of ICC. Combined immunoblot and RNA sequencing analyses revealed that LPCAT1 upregulates the expression of cell cycle proteins through activation of the PI3K/AKT signaling pathway, thereby promoting cellular proliferation and accelerating ICC progression.
Conclusions:
LPCAT1 upregulates cell cycle proteins through activation of the PI3K/AKT signaling pathway, thereby promoting cellular proliferation and accelerating ICC progression.
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:19Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...